NCT02573584View on ClinicalTrials.gov

Vascular Fingerprint Validation Study

CompletedOBSERVATIONAL
Enrollment

101

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

April 1, 2024

Study Completion Date

April 1, 2024

Conditions
Testicular Cancer
Trial Locations (5)

Unknown

Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis (NKI-AVL), Amsterdam

University Medical Center Groningen (UMCG), Groningen

Maastricht University Medical Center (MUMC), Maastricht

Instituto Portuges de Oncologia Francisco Gentil (IPOLFG), Lisbon

UniversitatsSpital Zurich, Zurich

All Listed Sponsors
lead

University Medical Center Groningen

OTHER

NCT02573584 - Vascular Fingerprint Validation Study | Biotech Hunter | Biotech Hunter